“It is important for the cancer patient to get tested for BRCA mutations because it not only has implications for their family, but their own treatment and prognosis. It becomes increasingly valuable to know a patient's BRCA status to guide and personalize treatment decisions.”
Society of Gynecologic Oncology 39th Annual Meeting – March 2008
Professor, Department of Gynecologic Oncology, M. D. Anderson Cancer Center.
"This is very promising technology that could change the standard protocols in screening breast cancer patients.”
David Page, MD, PhD
Komen Award of Scientific Distinction
Vanderbilt-Ingram Cancer Center
"This is an innovative approach to providing a quick important diagnosis, helping to determine the medical management of breast and ovarian cancer patients.”
Kenneth R. Shroyer, MD, PhD
Chairman, Department of Pathology
Stony Brook University Medical Center
“Personalized medicine, using therapies targeted to specific patient populations identified by molecular tests, are critical to the cost-effective practice of medicine.”
Steven Seelig, M.D., Ph.D., Medical News Today, medicalnewstoday.com
SERVICES "QUOTES"
